APA (7th ed.) Citation

KL, M., LC, L., & AM, K. (2026). Cenobamate in pediatric Dravet syndrome: Two responder cases highlighting the limits of simple "sodium-channel blocker" labeling. Frontiers in pharmacology, 17, 1809113. https://doi.org/10.3389/fphar.2026.1809113

Chicago Style (17th ed.) Citation

KL, Makridis, Laux LC, and Kaindl AM. "Cenobamate in Pediatric Dravet Syndrome: Two Responder Cases Highlighting the Limits of Simple "Sodium-channel Blocker" Labeling." Frontiers in Pharmacology 17 (2026): 1809113. https://doi.org/10.3389/fphar.2026.1809113.

MLA (9th ed.) Citation

KL, Makridis, et al. "Cenobamate in Pediatric Dravet Syndrome: Two Responder Cases Highlighting the Limits of Simple "Sodium-channel Blocker" Labeling." Frontiers in Pharmacology, vol. 17, 2026, p. 1809113, https://doi.org/10.3389/fphar.2026.1809113.